Cramer: Apple Is Th...
Health Care: Health Services
Covidien PLC (COV: NYSE)
$50.67 -1.11 | -2.14%
06/01/12 - 04:01 PM ET
Company Balance Sheet
| Sep 2011 | Sep 2010 | Sep 2009 | Sep 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 1.50B | 1.56B | 1.47B | 1.21B |
| Receivables | 1.75B | 1.71B | 1.88B | 1.81B |
| Inventories | 1.51B | 1.38B | 1.33B | 1.28B |
| Other Current Assets | 0.00 | 245.00M | 0.00 | 347.00M |
| Total Current Assets | 5.77B | 5.74B | 5.46B | 5.29B |
| Property, Plant & Equipment, Gross | 5.34B | 4.99B | 4.93B | 4.49B |
| Accumulated Depreciation & Depletion | 2.63B | 2.38B | 2.27B | 2.01B |
| Property, Plant & Equipment, Net | 2.70B | 2.61B | 2.66B | 2.48B |
| Intangibles | 2.76B | 2.95B | 1.56B | 1.22B |
| Other Non-Current Assets | 1.45B | 1.42B | 1.41B | 1.14B |
| Total Non-Current Assets | 14.60B | 14.65B | 11.68B | 10.71B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 20.37B | 20.39B | 17.14B | 16.00B |
| Accounts Payable | 576.00M | 586.00M | 500.00M | 522.00M |
| Short Term Debt | 11.00M | 255.00M | 30.00M | 19.00M |
| Other Current Liabilities | 202.00M | 1.09B | 146.00M | 197.00M |
| Total Current Liabilities | 2.40B | 3.13B | 2.24B | 2.10B |
| Long Term Debt | 4.20B | 4.45B | 2.96B | 2.99B |
| Deferred Income Taxes | 745.00M | 781.00M | 2.97B | 334.00M |
| Other Non-Current Liabilities | 3.22B | 3.06B | 970.00M | 2.84B |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 8.16B | 8.29B | 6.90B | 6.16B |
| Total Liabilities | 10.56B | 11.41B | 9.14B | 8.26B |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 9.82B | 8.97B | 8.00B | 7.75B |
| Common Par | 103.00M | 101.00M | 100.00M | 101.00M |
| Additional Paid In Capital | 6.84B | 6.56B | 6.17B | 6.09B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 3.91B | 2.44B | 1.20B | 681.00M |
| Treasury Stock | -1.44B | -484.00M | 0.00 | 0.00 |
| Other Equity Adjustments | 398.00M | 350.00M | 529.00M | 879.00M |
| Total Capitalization | 14.01B | 13.42B | 10.96B | 10.73B |
| Total Equity | 9.82B | 8.97B | 8.00B | 7.75B |
| Total Liabilities & Stock Equity | 20.37B | 20.39B | 17.14B | 16.00B |
| Total Common Shares Outstanding | 481.96M | 495.08M | 499.30M | 503.16M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 31.83M | 12.16M | 3.98M | 0.00 |
| Basic Weighted Shares Outstanding | 493.00M | 500.00M | 503.00M | 500.00M |
| Diluted Weighted Shares Outstanding | 497.00M | 504.00M | 505.00M | 505.00M |
| Number of Employees | 41300 | 41500 | 41800 | 41700 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with COV
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 16
- ProJohn Paulson
- ContributorTop-Yielding Health Service...
- UserGFNN Stockdiagnostics 4
- ProKaren Finerman - Metropolit...
- ProPrivate Capital Management
- ContributorHealth Care Stocks Bought a...
- ContributorJohn Paulson's 10 Best New ...
- Contributor8 Health Care Stocks to Buy
- ProTPG-Axon Capital
Latest COV Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Europe's Problems a Global Problem 06.01.12 | 07:06 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.24.12 | 05:05 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.08.12 | 04:05 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.01.12 | 05:05 pm
- Covidien's CEO Discusses Q2 2012 Results - Earnings Call Transcript 04.27.12 | 01:04 pm
- Covidien Stock To Go Ex-dividend Monday (COV) 03.30.12 | 09:03 am
- 8 Ex-Dividend Stocks With Buy Ratings 03.30.12 | 05:03 am
- Tyco Investors Not Free From Kozlowski 03.29.12 | 09:03 am
- Pfizer Needs to Think About Splitting: Goldman 03.27.12 | 03:03 pm
- Cramer's 'Mad Money' Recap: Balancing Act (Final) 02.08.12 | 07:02 pm
Press Releases for COV
- Endo GIA(TM) Radial Reload With Tri-Staple(TM) Technology (Photo: Business Wire) - Business Wire 05.31.12 | 06:05 pm
- Covidien To Present At Goldman Sachs Conference - Business Wire 05.31.12 | 07:05 am
- Covalon Provides Corporate Update And Second Quarter Fiscal 2012 Financial Results - PR Newswire 05.28.12 | 08:05 am
- Covidien Announces Pricing Of $1.250 Billion Senior Notes Offering - Business Wire 05.22.12 | 04:05 pm
- Covidien Announces Senior Notes Offering And Redemption Of 5.450% Senior Notes Due October 2012 - Business Wire 05.22.12 | 09:05 am
- Covidien Appoints Gregory S. Andrulonis Vice President And Treasurer - Business Wire 05.21.12 | 04:05 pm
- Covalon To Unveil Its SilverCoat⢠Antimicrobial Silicone Foley Catheter At The 2012 American Urological Association Annual Meeting In Atlanta - PR Newswire 05.18.12 | 01:05 pm
- Covidien Completes Acquisition Of SuperDimension, Ltd. - Business Wire 05.15.12 | 04:05 pm
- Covalon Announces Major Milestone: Achieves FDA Approval For IV Clear⢠- A Breakthrough Antimicrobial Silicone Adhesive Film Dressing For Securing Vascular Access Medical Devices - PR Newswire 05.15.12 | 08:05 am
- Covidien, A Leading Global Provider Of Healthcare Products, Will Unveil Its New OneShot™ Renal Denervation System At The EuroPCR Congress In Paris, France, On May 16, 2012. (Photo: Business Wire) - Business Wire 05.08.12 | 07:05 am
Partner Headlines for COV
- COV Launches Endo GIA Radial Reload - Analyst Blog - Zacks 06.01.12 | 05:06 pm
- Covidien Prices Senior Notes - Analyst Blog - Zacks 05.25.12 | 04:05 pm
- John Paulson Buys Almost 10 Percent of Caesar's, Buffett's Viacom and NOV, COV, ABVT, TNB - GuruFocus 05.17.12 | 04:05 pm
- John Paulson Buys Almost 10 Percent of Caesar's, Buffett's Viacom - GuruFocus 05.17.12 | 04:05 pm
- The Zacks Analyst Blog Highlights: Covidien, General Electrical, Becton, Dickinson and Company, Johnson and Johnson and CR Bard - Press Releases - Zacks 05.14.12 | 09:05 am
- UPDATE: Deutsche Bank Raises PT to $62 on Covidien; FQ2 Beats Expectations - Benzinga 05.01.12 | 09:05 am
- Covidien to Acquire Oridion Systems - Analyst Blog - Zacks 04.13.12 | 04:04 pm
- Covidien Takes Over superDimension - Analyst Blog - Zacks 04.03.12 | 09:04 am
- Covidien Announces Study Results Demonstrating Benefits of Minimally Invasive Surgery over Traditional Open Procedures - Benzinga 03.12.12 | 04:03 pm
- The Zacks Analyst Blog Highlights: Applied Materials, Covidien, Johnson & Johnson, Becton Dickinson and C.R. Bard - Press Releases - Zacks 03.08.12 | 09:03 am
